0 avis
Contribution of TRPC channels in human and experimental pulmonary arterial hypertension. Contribution of TRPC channels in human and experimental pulmonary arterial hypertension: Short title : TRPC channels in PAH
Archive ouverte
Edité par CCSD ; American Physiological Society -
International audience. TRPC3 is increased in human and experimental pulmonary arterial hypertension (PAH). In PAH pulmonary arterial smooth muscle cells, TRPC3 participates in the aberrant store-operated Ca 2+ entry contributing to their pathological cell phenotypes (exacerbated proliferation, enhanced migration, apoptosis resistance, and vasoconstriction). Pharmacological in vivo inhibition of TRPC3 reduces the development of experimental PAH. Even if other TRPC acts on PAH development, our results prove that TRPC3 inhibition could be considered as an innovative treatment for PAH.